|
Adverse Effects
Citations 461-470 of 594 total displayed.
|
Past content
(since Mar 1998):
|
- Letters
Cardiovascular Effects of Ephedra
- Mori J. Krantz
JAMA 2004; 291: 1560.
[Extract]
[Full text]
[PDF]
- Letters
Olanzapine vs Haloperidol for Treatment of Schizophrenia
- William M. Glazer
JAMA 2004; 291: 1064-a-1065-a.
[Extract]
[Full text]
[PDF]
- Letters
Olanzapine vs Haloperidol for Treatment of Schizophrenia
- Jan Volavka; Leslie Citrome
JAMA 2004; 291: 1064.
[Extract]
[Full text]
[PDF]
- Letters
Olanzapine vs Haloperidol for Treatment of Schizophrenia—Reply
- Robert Rosenheck; Deborah Perlick; Stephen Bingham; Joseph Collins
JAMA 2004; 291: 1065-c-1066-c.
[Extract]
[Full text]
[PDF]
- Letters
Olanzapine vs Haloperidol for Treatment of Schizophrenia
- Lieuwe de Haan; Nico van Beveren
JAMA 2004; 291: 1065-b.
[Extract]
[Full text]
[PDF]
- Letters
Olanzapine vs Haloperidol for Treatment of Schizophrenia
- Michal Kunz
JAMA 2004; 291: 1065-a.
[Extract]
[Full text]
[PDF]
- Letters
Olanzapine vs Haloperidol for Treatment of Schizophrenia
- Mo Amin; Vijay S. Shukla
JAMA 2004; 291: 1065.
[Extract]
[Full text]
[PDF]
- Letters
Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder
- Boghos I. Yerevanian; Ralph J. Koek; Jamie D. Feusner
JAMA 2004; 291: 939-a.
[Extract]
[Full text]
[PDF]
- Letters
Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder
- Charles Bowden; Jan Fawcett
JAMA 2004; 291: 939.
[Extract]
[Full text]
[PDF]
- Letters
Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder—Reply
- Frederick K. Goodwin; Greg Simon; Dennis Revicki; Enid Hunkeler; Bruce Fireman; Janelle Lee
JAMA 2004; 291: 940.
[Extract]
[Full text]
[PDF]
|
|
